ELLA™ Receives Independent IRB Exemption Determination, Setting a New Standard for Ethical AI in Clinical Research
SOGLIA's ELLA, an emotionally intelligent AI patient-experience platform for clinical trials, received an independent IRB exemption determination. The decision positions ELLA as ethically cleared for certain human-subject interactions and signals broader acceptance of AI tools in trial recruitment and engagement.
Why it mattersIndependent IRB exemption for ELLA's AI reduces review burden for trial engagement tools, speeding deployment decisions.